TAS SANIT SABA CONF MZLLA NOCT C/A8 HIDROCLOROTIAZIDA 12.50 MG TELMISARTAN 80.00 MG DOSIS: 120/200 MG

Description

DOSIS: 120/200 MG

Rotar sitios de inyección (brazo

GIOTRIF® 40 mg es un medicamento oncológico cuyo principio activo es Afatinib

Vía de administración: Intramuscular (IM) o intravenosa (IV) según indicación médica

FABRICANTE: KENER

TAS SANIT SABA CONF MZLLA NOCT C/A8 HIDROCLOROTIAZIDA 12.50 MG TELMISARTAN 80.00 MG DOSIS: 120/200 MGBolsa C 8 Piezas

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy